Skip to content

TMO

Thermo Fisher Scientific Inc.

Income statement

Income statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue47.4B44.6B42.9B42.9B44.9B39.2B32.2B25.5B24.4B20.9B18.3B17.0B16.9B13.1B12.5B11.6B10.4B9.9B10.5B9.7B
Cost of revenue
—26.3B25.2B25.8B25.9B19.6B16.2B——11.5B9.9B9.2B9.4B7.6B7.2B6.8B6.1B6.0B6.3B5.9B
Gross profit—18.2B17.7B17.1B19.0B19.6B16.0B——9.4B8.4B7.8B7.5B5.5B5.3B4.8B4.3B3.9B4.2B3.8B
1.40B1.40B1.39B1.34B1.47B1.41B1.18B1.00B0.97B0.89B0.75B0.69B0.69B0.40B0.38B0.34B0.28B———
9.19B8.73B8.60B8.45B8.99B8.01B6.93B6.14B6.06B5.50B4.97B4.61B4.90B3.45B3.35B3.11B2.73B2.59B2.69B2.55B
Other operating expenses
—363M380M459M114M197M99M——94M186M116M—78M82M97M60M303M285M281M
Operating income8.5B7.7B7.3B6.9B8.4B10.0B7.8B4.6B3.8B3.0B2.5B2.3B2.5B1.6B1.5B1.3B1.2B1.0B1.2B974M
Non-operating income
−0.57B−0.44B−0.30B−0.56B−0.56B−1.19B−0.57B−0.52B−0.52B−0.53B−0.43B−0.40B−0.42B−0.29B−0.21B−0.12B−0.10B−0.12B——
Pretax income7.90B7.31B7.04B6.30B7.84B8.84B7.23B4.07B3.26B2.43B2.02B1.94B2.09B1.32B1.27B1.13B1.09B0.88B——
Taxes
0.83B0.60B0.70B0.30B0.89B1.12B0.85B0.37B0.32B0.20B2.0M−39M0.19B46M92M−0.20B52M30M——
Net income7.07B6.70B6.34B6.00B6.95B7.73B6.38B3.70B2.94B2.23B2.02B1.98B1.89B1.27B1.18B1.33B1.04B0.85B0.98B0.75B
Diluted EPS18.9617.7416.5315.4517.6319.4615.969.177.245.595.094.924.713.483.213.462.532.012.251.69
Diluted shares—378.0M383.0M388.0M394.0M397.0M399.0M403.0M406.0M398.0M397.0M402.0M402.3M365.8M366.6M384.8M409.4M422.8M434.7M443.6M
Revenue growth—+3.9%+0.1%−4.6%+14.5%+21.7%+26.1%+4.9%+16.4%+14.5%+7.7%+0.4%+29.0%+4.6%+8.2%+11.2%+4.9%−5.6%+7.7%—
Gross margin—40.9%41.3%39.9%42.2%50.1%49.7%——45.2%45.8%45.7%44.4%42.2%42.3%41.5%41.0%39.3%40.1%39.0%
Operating margin17.9%17.4%17.1%16.0%18.7%25.6%24.2%18.0%15.5%14.2%13.5%13.8%14.8%12.3%11.8%10.8%11.4%10.1%11.7%10.0%
Net margin14.9%15.0%14.8%14.0%15.5%19.7%19.8%14.5%12.1%10.6%11.1%11.6%11.2%9.7%9.4%11.5%10.0%8.6%9.3%7.7%